Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.
about
Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation.Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.
P2860
Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Allogeneic stem cell transplan ...... ens in severe aplastic anemia.
@en
type
label
Allogeneic stem cell transplan ...... ens in severe aplastic anemia.
@en
prefLabel
Allogeneic stem cell transplan ...... ens in severe aplastic anemia.
@en
P2093
P2860
P1476
Allogeneic stem cell transplan ...... ens in severe aplastic anemia.
@en
P2093
A G Kulasekararaj
J C W Marsh
P2860
P2888
P304
P356
10.1007/S12185-013-1333-9
P577
2013-04-30T00:00:00Z
P5875
P6179
1035869494